{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:45:07Z","timestamp":1765233907063,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006389","name":"University of Geneva","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006389","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Somatic variant testing through next-generation sequencing (NGS) is well integrated into Swiss molecular pathology laboratories and has become a standard diagnostic method for numerous indications in cancer patient care. Currently, there is a wide variation in reporting practices within our country, and as patients move between different hospitals, it is increasingly necessary to standardize NGS reports to ease their reinterpretation. Additionally, as many different stakeholders\u2014oncologists, hematologists, geneticists, pathologists, and patients\u2014have access to the NGS report, it needs to contain comprehensive and detailed information in order to answer the questions of experts and avoid misinterpretation by non-experts. In 2017, the Swiss Institute of Bioinformatics conducted a survey to assess the differences in NGS reporting practices across ten pathology institutes in Switzerland. The survey examined 68 reporting items and identified 48 discrepancies. Based on these findings, the Swiss Society of Molecular Pathology initiated a Delphi method to reach a consensus on a set of recommendations for NGS reporting. Reports should include clinical information about the patient and the diagnosis, technical details about the sample and the test performed, and a list of all clinically relevant variants and variants of uncertain significance. In the absence of a consensus on an actionability scheme, the five-class pathogenicity scheme proposed by the ACMG\/AMP guideline must be included in the reports. The Swiss Society of Molecular Pathology recognizes the importance of including clinical actionability in the report and calls on the European community of molecular pathologists and oncologists to reach a consensus on this issue.<\/jats:p>","DOI":"10.1007\/s00428-024-03951-0","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T19:02:23Z","timestamp":1729710143000},"page":"1033-1039","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reporting of somatic variants in clinical cancer care: recommendations of the Swiss Society of Molecular Pathology"],"prefix":"10.1007","volume":"485","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4977-1362","authenticated-orcid":false,"given":"Yann","family":"Christinat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baptiste","family":"Hamelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Alborelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Angelino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Barbi\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Bisig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milo","family":"Frattini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Grob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfram","family":"Jochum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronny","family":"Nienhold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"McKee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Matter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Missiaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sacha","family":"Rothschild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Bettina","family":"Sobottka-Brillout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Vassella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Zoche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten D.","family":"Mertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"3951_CR1","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3390\/biology12070997","volume":"12","author":"H Satam","year":"2023","unstructured":"Satam H, Joshi K, Mangrolia U et al (2023) Next-generation sequencing technology: current trends and advancements. Biology (Basel) 12:997. https:\/\/doi.org\/10.3390\/biology12070997","journal-title":"Biology (Basel)"},{"key":"3951_CR2","doi-asserted-by":"publisher","first-page":"100839","DOI":"10.1016\/j.lanepe.2024.100839","volume":"38","author":"VD de Jager","year":"2024","unstructured":"de Jager VD, Timens W, Bayle A et al (2024) Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer. Lancet Reg Health Eur 38:100839. https:\/\/doi.org\/10.1016\/j.lanepe.2024.100839","journal-title":"Lancet Reg Health Eur"},{"key":"3951_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.32074\/1591-951X-895","volume":"115","author":"U Malapelle","year":"2023","unstructured":"Malapelle U, Angerilli V, Pepe F et al (2023) The ideal reporting of RAS testing in colorectal adenocarcinoma: a pathologists\u2019 perspective. Pathologica 115:137\u2013147. https:\/\/doi.org\/10.32074\/1591-951X-895","journal-title":"Pathologica"},{"key":"3951_CR4","doi-asserted-by":"publisher","unstructured":"Malapelle U, Donne AD, Pagni F et al (2024) Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: practical indications from an Italian multidisciplinary group. Crit Rev Oncol Hematol 193. https:\/\/doi.org\/10.1016\/J.CRITREVONC.2023.104217","DOI":"10.1016\/J.CRITREVONC.2023.104217"},{"key":"3951_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/S00428-023-03702-7","volume":"484","author":"JM Riedl","year":"2024","unstructured":"Riedl JM, Moik F, Esterl T et al (2024) Molecular diagnostics tailoring personalized cancer therapy-an oncologist\u2019s view. Virchows Arch 484:169\u2013179. https:\/\/doi.org\/10.1007\/S00428-023-03702-7","journal-title":"Virchows Arch"},{"key":"3951_CR6","doi-asserted-by":"publisher","unstructured":"Schmid S, Jochum W, Padberg B et al (2022) How to read a next-generation sequencing report-what oncologists need to know. ESMO Open 7. https:\/\/doi.org\/10.1016\/J.ESMOOP.2022.100570","DOI":"10.1016\/J.ESMOOP.2022.100570"},{"key":"3951_CR7","doi-asserted-by":"publisher","unstructured":"Remon J, Dienstmann R (2018) Precision oncology: separating the wheat from the chaff. ESMO Open 3. https:\/\/doi.org\/10.1136\/ESMOOPEN-2018-000446","DOI":"10.1136\/ESMOOPEN-2018-000446"},{"key":"3951_CR8","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/JAMIA\/OCX150","volume":"25","author":"SW Gray","year":"2018","unstructured":"Gray SW, Gagan J, Cerami E et al (2018) Interactive or static reports to guide clinical interpretation of cancer genomics. J Am Med Inform Assoc 25:458\u2013464. https:\/\/doi.org\/10.1093\/JAMIA\/OCX150","journal-title":"J Am Med Inform Assoc"},{"key":"3951_CR9","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/J.GIM.2022.01.001","volume":"24","author":"P Horak","year":"2022","unstructured":"Horak P, Griffith M, Danos AM et al (2022) Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). Genet Med 24:986\u2013998. https:\/\/doi.org\/10.1016\/J.GIM.2022.01.001","journal-title":"Genet Med"},{"key":"3951_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4132\/JPTM.2017.03.14","volume":"51","author":"J Kim","year":"2017","unstructured":"Kim J, Park WY, Kim NKD et al (2017) Good laboratory standards for clinical next-generation sequencing cancer panel tests. J Pathol Transl Med 51:191\u2013204. https:\/\/doi.org\/10.4132\/JPTM.2017.03.14","journal-title":"J Pathol Transl Med"},{"key":"3951_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/J.JMOLDX.2016.10.002","volume":"19","author":"MM Li","year":"2017","unstructured":"Li MM, Datto M, Duncavage EJ et al (2017) Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn 19:4\u201323. https:\/\/doi.org\/10.1016\/J.JMOLDX.2016.10.002","journal-title":"J Mol Diagn"},{"key":"3951_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/S00428-017-2108-0","volume":"471","author":"V Tack","year":"2017","unstructured":"Tack V, Dufraing K, Deans ZC et al (2017) The ins and outs of molecular pathology reporting. Virchows Arch 471:199\u2013207. https:\/\/doi.org\/10.1007\/S00428-017-2108-0","journal-title":"Virchows Arch"},{"key":"3951_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/S00428-016-2025-7","volume":"470","author":"ZC Deans","year":"2017","unstructured":"Deans ZC, Costa JL, Cree I et al (2017) Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL. Virchows Arch 470:5\u201320. https:\/\/doi.org\/10.1007\/S00428-016-2025-7","journal-title":"Virchows Arch"},{"key":"3951_CR14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/JCLINPATH-2014-202404","volume":"67","author":"IA Cree","year":"2014","unstructured":"Cree IA, Deans Z, Ligtenberg MJL et al (2014) Guidance for laboratories performing molecular pathology for cancer patients. J Clin Pathol 67:923\u2013931. https:\/\/doi.org\/10.1136\/JCLINPATH-2014-202404","journal-title":"J Clin Pathol"},{"key":"3951_CR15","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1002\/IJC.32358","volume":"145","author":"J Leichsenring","year":"2019","unstructured":"Leichsenring J, Horak P, Kreutzfeldt S et al (2019) Variant classification in precision oncology. Int J Cancer 145:2996\u20133010. https:\/\/doi.org\/10.1002\/IJC.32358","journal-title":"Int J Cancer"},{"key":"3951_CR16","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1111\/CAS.15833","volume":"114","author":"H Kage","year":"2023","unstructured":"Kage H, Oda K, Muto M et al (2023) Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan. Cancer Sci 114:3041\u20133049. https:\/\/doi.org\/10.1111\/CAS.15833","journal-title":"Cancer Sci"},{"key":"3951_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/S41436-019-0618-7","volume":"22","author":"K Schwarze","year":"2020","unstructured":"Schwarze K, Buchanan J, Fermont JM et al (2020) The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom. Genet Med 22:85\u201394. https:\/\/doi.org\/10.1038\/S41436-019-0618-7","journal-title":"Genet Med"},{"key":"3951_CR18","doi-asserted-by":"publisher","unstructured":"Hsu C-C, Sandford BA (2007) The Delphi technique: making sense of consensus. Pract Assess, Res Evaluation 12. https:\/\/doi.org\/10.7275\/PDZ9-TH90","DOI":"10.7275\/PDZ9-TH90"},{"key":"3951_CR19","doi-asserted-by":"publisher","first-page":"221\u2013230","DOI":"10.1200\/CCI.20.00108","volume":"5","author":"R Kundra","year":"2021","unstructured":"Kundra R, Zhang H, Sheridan R et al (2021) OncoTree: a cancer classification system for precision oncology. JCO Clin Cancer Inform 5:221\u2013230. https:\/\/doi.org\/10.1200\/CCI.20.00108","journal-title":"JCO Clin Cancer Inform"},{"key":"3951_CR20","unstructured":"ICD-11. https:\/\/icd.who.int\/en. Accessed 6 Aug 2024"},{"key":"3951_CR21","unstructured":"HL7 FHIR v5.0.0. https:\/\/www.hl7.org\/fhir\/. Accessed 6 Aug 2024"},{"key":"3951_CR22","unstructured":"Conf\u00e9d\u00e9ration suisse (2022) FedLex RO 2022 585 - Ordonnance sur l\u2019analyse g\u00e9n\u00e9tique humaine. https:\/\/www.fedlex.admin.ch\/eli\/oc\/2022\/585\/fr. Accessed 9 Jul 2024"},{"key":"3951_CR23","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1093\/ANNONC\/MDY263","volume":"29","author":"J Mateo","year":"2018","unstructured":"Mateo J, Chakravarty D, Dienstmann R et al (2018) A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT). Ann Oncol 29:1895\u20131902. https:\/\/doi.org\/10.1093\/ANNONC\/MDY263","journal-title":"Ann Oncol"},{"key":"3951_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/GIM.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/GIM.2015.30","journal-title":"Genet Med"},{"key":"3951_CR25","doi-asserted-by":"publisher","first-page":"D1210","DOI":"10.1093\/NAR\/GKAD986","volume":"52","author":"Z Sondka","year":"2024","unstructured":"Sondka Z, Dhir NB, Carvalho-Silva D et al (2024) COSMIC: a curated database of somatic variants and clinical data for cancer. Nucleic Acids Res 52:D1210\u2013D1217. https:\/\/doi.org\/10.1093\/NAR\/GKAD986","journal-title":"Nucleic Acids Res"},{"key":"3951_CR26","doi-asserted-by":"publisher","unstructured":"Chakravarty D, Gao J, Phillips S et al (2017) OncoKB: a precision oncology knowledge base. JCO Precis Oncol 1\u201316. https:\/\/doi.org\/10.1200\/PO.17.00011","DOI":"10.1200\/PO.17.00011"},{"key":"3951_CR27","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1038\/s41375-021-01436-6","volume":"35","author":"EA Bruford","year":"2021","unstructured":"Bruford EA, Antonescu CR, Carroll AJ et al (2021) HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions. Leukemia 35:3040\u20133043. https:\/\/doi.org\/10.1038\/s41375-021-01436-6","journal-title":"Leukemia"},{"key":"3951_CR28","doi-asserted-by":"publisher","unstructured":"El Osta B (2023) KRAS G12C mutation: from undruggable target to potentially agnostic biomarker. Transl Lung Cancer Res 12:1147\u20131151. https:\/\/doi.org\/10.21037\/TLCR-23-174","DOI":"10.21037\/TLCR-23-174"},{"key":"3951_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jmoldx.2022.11.002","volume":"25","author":"MM Li","year":"2023","unstructured":"Li MM, Cottrell CE, Pullambhatla M et al (2023) Assessments of somatic variant classification using the Association for Molecular Pathology\/American Society of Clinical Oncology\/College of American Pathologists Guidelines: a report from the Association for Molecular Pathology. J Mol Diagn 25:69\u201386. https:\/\/doi.org\/10.1016\/j.jmoldx.2022.11.002","journal-title":"J Mol Diagn"},{"key":"3951_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.EJCA.2021.08.047","volume":"159","author":"F Koeppel","year":"2021","unstructured":"Koeppel F, Muller E, Harl\u00e9 A et al (2021) Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies. Eur J Cancer 159:1\u201315. https:\/\/doi.org\/10.1016\/J.EJCA.2021.08.047","journal-title":"Eur J Cancer"},{"key":"3951_CR31","doi-asserted-by":"publisher","unstructured":"Li Q, Ren Z, Cao K et al (2022) CancerVar: An artificial intelligence-empowered platform for clinical interpretation of somatic mutations in cancer. Sci Adv 8. https:\/\/doi.org\/10.1126\/SCIADV.ABJ1624","DOI":"10.1126\/SCIADV.ABJ1624"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03951-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-024-03951-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03951-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T13:09:51Z","timestamp":1734959391000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-024-03951-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["3951"],"URL":"https:\/\/doi.org\/10.1007\/s00428-024-03951-0","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"type":"print","value":"0945-6317"},{"type":"electronic","value":"1432-2307"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not involve any human or animal subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}